Hikma Pharmaceutical | HIK - EPS Earnings Per Share


Hikma Pharmaceutical reported $0.65 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024H1 Jun/2024 0.13 458.0000 Aug/08




Eps Change Date
Almirall EUR 0.2 0.13 Jun/2026
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Autolus Therapeutics Ltd USD -0.15 0.12 Jun/2026
Bayer EUR 0.31 0.64 Sep/2026
Fresenius EUR 0.86 0.03 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GRIFOLS EUR 0.3 0.07 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.23 0.03 Sep/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.04 2.58 Sep/2026
Orion EUR 1.19 0.19 Sep/2026
Recordati EUR 0.66 0.01 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025